Over 7,000 Yorkshire and Humber patients across 10 sites have benefitted from improving the Adenoma Detection Rate (ADR) and cancer detection in 2019-20. This is through improved colonoscopy performance using Endocuff Vision.
Endocuff Vision is a medical device that attaches to an endoscope to improve colorectal examination for patients undergoing bowel cancer tests. Bowel cancer is the fourth most common cancer in England with 34,000 people diagnosed each year. For every 1,000 patients treated it is estimated that six cases of cancer could be avoided through use of this device.